Improving the quality of cancer clinical trials : workshop summary /

Scientists and clinicians seek a new paradigm that could improve the efficiency, cost-effectiveness, and overall success rate of cancer clinical trials, while maintaining the highest standards of quality. To explore innovative paradigms for cancer clinical trials and other ways to improve their qual...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores Corporativos: National Cancer Policy Forum (U.S.), Institute of Medicine (U.S.)
Otros Autores: Patlak, Margie, Nass, Sharyl J.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, ©2008.
Temas:
Cancer > Treatment > United States.
Clinical trials.
Neoplasms > drug therapy
Clinical Trials as Topic
Cancer > Traitement > États-Unis.
Études cliniques.
HEALTH & FITNESS > Diseases > Cancer.
Cancer > Treatment
Clinical trials
United States
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Introduction
  • New clinical trial designs. Phase 0 trials
  • Adaptive trial designs
  • Targeting multiple pathways with multiple drugs
  • Preclinical model systems
  • Molecular imaging. Current and developing methods
  • Challenges of molecular imaging
  • Screening for predictive markers. The challenges of clinical validation
  • Bioimaging predictive markers
  • Clinical translation
  • Panel discussion
  • Costs of clinical trials. Regulatory costs
  • Patient accrual
  • Global outsourcing
  • Time is money
  • Public-private collaborations
  • Regulatory issues. Regulatory barriers to innovation
  • Patient advocacy perspective
  • Regulation of in vitro diagnostics
  • Regulatory issues in improving cancer clinical trials
  • Reports from the case study discussion groups. Adaptive trial design
  • Phase 0 trials
  • Imaging
  • Use of proteomics/genomics to assign therapy in lung cancer
  • Use of genetics/genomics to assign therapy.

Ejemplares similares